SPOT Platinum+
Commercial- Indications
- Animal allergies
Company intelligence / Profile preview
Nextmune operates globally with over three decades of experience in pet allergy diagnostics and treatment. It claims a leading position in veterinary allergy management with proprietary diagnostic tests and immunotherapy products. Its Artuvetrin serum therapy is the only licensed veterinary allergy immunotherapy in Europe. The company reports treating over one million patients worldwide across more than seventy countries.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nextmune.